Albireo Pharma ALBO

Quarterly report 2022-Q3
added 11-08-2022

Albireo Pharma DIO Ratio 2011-2026 | ALBO

Annual DIO Ratio Albireo Pharma

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
26.1	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
26.1	26.1	26.1

Quarterly DIO Ratio Albireo Pharma

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	391	230	393	-	20.8	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
393	20.8	259

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	Acorda Therapeutics ACOR	345	-	-24.86 %	$ 820 K	USA
	Aytu BioScience AYTU	209	$ 2.71	1.88 %	$ 17 M	USA
	Amphastar Pharmaceuticals AMPH	132	$ 25.87	-0.79 %	$ 1.25 B	USA
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	BeiGene, Ltd. BGNE	304	-	0.49 %	$ 251 B	Cayman-islands
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	Acasti Pharma ACST	136	-	4.01 %	$ 150 M	Canada
	Baudax Bio BXRX	596	-	0.59 %	$ 63 K	USA
	CASI Pharmaceuticals CASI	47.4	$ 0.95	-0.72 %	$ 129 M	USA
	Catalyst Biosciences CBIO	410	$ 14.01	3.7 %	$ 922 M	USA
	Biogen BIIB	394	$ 164.87	0.27 %	$ 24 B	USA
	Avid Bioservices CDMO	102	-	-	$ 789 M	USA
	Catalyst Pharmaceuticals CPRX	93.3	$ 23.32	2.71 %	$ 2.76 B	USA